[Asia Economy Reporter Hwang Yoon-joo] SK Bioscience announced on the 7th that its individual operating profit for the fourth quarter of last year was 253.9 billion KRW, an increase of 2227% compared to the same period last year. During the same period, sales amounted to 450.8 billion KRW, up 572.8%, and net profit was 183.9 billion KRW, up 1762.4%.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing